Sho-saiko-to

DIETARY_SUPPLEMENT2 trials

Sponsors

Memorial Sloan Kettering Cancer Center

Conditions

Hepatitis CLiver Cancer

Phase 2

Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed

CompletedNCT00040898

Memorial Sloan Kettering Cancer CenterLiver Cancer

Start: 2001-01-31Updated: 2013-01-18

SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study

CompletedNCT00590564

Memorial Sloan Kettering Cancer CenterHepatitis C

Start: 2002-10-31End: 2011-02-28Updated: 2016-01-15